Regulus Therapeutics Inc’s latest rating changes from various analysts
In a filing, Regulus Therapeutics Inc revealed its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0 on Jan 18 ’24. In the deal valued at $1.19 per share,14,580 shares were sold. As a result of this transaction, Hagan Joseph P now holds 57,112 shares worth roughly $0.15 million. Then, CALSADA CRISPINA […]
Leerink Partners analysts initates an Outperform rating for Regulus Therapeutics Inc (RGLS)
Regulus Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Hagan Joseph P unloaded Company’s shares for reported $17359.0 on Jan 18 ’24. In the deal valued at $1.19 per share,14,580 shares were sold. As a result of this transaction, Hagan Joseph P now holds 57,112 shares worth roughly $0.15 million. Then, CALSADA CRISPINA […]
